Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years

Movement Disorders

Volumn 8, Issue 2, 1993, Pages 165-170

  Hughes, A J ^a   Bishop, Susan ^a   Kleedorfer, Birgit ^a   Turjanski, Nora ^a   Fernandez, W ^a   Lees, A J ^a   Stern, G M ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Apomorphine; Motor fluctuations; Parkinson's disease

Indexed keywords

APOMORPHINE; CENTRAL STIMULANT AGENT; DOMPERIDONE; LEVODOPA;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG RESISTANCE; DYSKINESIA; FEMALE; HEMOLYTIC ANEMIA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPSYCHIATRY; PARKINSON DISEASE; SEDATION; SKIN MANIFESTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; APOMORPHINE; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFUSION PUMPS; INJECTIONS, SUBCUTANEOUS; LEVODOPA; LONG-TERM CARE; MALE; MIDDLE AGE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; SUPPORT, NON-U.S. GOV'T;

EID: 0027264828     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.870080208     Document Type: Article

References (22)

1. Diurnal responsiveness apomorphine
2. Comparison of the motor response to apomorphine and levodopa in Parkinson's disease
3. Apomorphine in Parkinson's disease
4. Similarities between neurological effects of l‐dopa and of apomorphine
5. Therpeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease
6. On‐off fluctuations in Parkinson's diseae. A clinical and neuropharmacological study
7. Cholinergic and dopaminergic mechanisms in Parkinson's disease after long‐term levodopa administration
8. Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on‐off fluctuation
9. Psychiatric side‐effects of high dose lisuride therapy in parkinsonism
10. Subcutaneous lisuride infusion in Parkinson's disease; response to chronic administration in 34 patients
11. Long‐term duodenal infusion of levodopa for motor fluctuations in parkinsonism
12. The effects of oral protein on the absorption of intraduodenal levodopa and motor performance
13. Subcutaneous apomorphine in parkinsonian on‐off oscillations
14. Subcutaneous apomorphine in Parkinson's disease
15. Subcutaneous apomorphine for on‐off oscillations in Parkinson's disease
16. Administration souscoutanée d'apomorphine dans les fluctuations matrices de la maladie de Parkinson
17. Subcutaneous apomorphine in the treatment of Parkinson's disease
18. Subcutaneous apomorphine in fluctuating Parkinson's disease–long‐term follow‐up results in 22 patients
19. Intranasal apomorphine in Parkinson's disease
20. Sublingual apomorphine and Parkinson's disease
21. Rectal apomorphine in Parkinson's disease
22. Off‐period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease; treatment with apomorphine